George Kemble, Executive Chairman at Sagimet Biosciences Inc. (SGMT), sold 75,376 shares at $7.69 ($580K) on 2025-11-20, disclosed to the SEC on 2025-11-21.
Scheduled sale ($580k) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.69 | 37,688 | $290K | 50.0% |
| 2 | $7.69 | 37,688 | $290K | 50.0% |
| Total | $7.69 avg | 75,376 | $580K | 100% |
| Filing → |
| SGMT | SELL | 2026-07-22 | $141K | — | Filing → |
| SGMT | SELL | 2024-07-25 | $150K | — | Filing → |
| SGMT | SELL | 2024-07-23 | $44K | — | Filing → |